Publication: Drug Discovery & Development
The article explores how using biosimulation for rare disease drug development can help overcome challenges in traditional clinical trials. Experts from Certara- Drs. Rajesh Krishna and Oxana Iliach, highlight how these technologies can be used to enhance statistical precision, create virtual cohorts, simulate control arms, and optimize trial designs. The discussion also covers policy changes and collaborative frameworks to boost accessibility and development in the rare disease space.
Published: 2025 年 3 月 14 日
Learn more about Rare and Neglected Diseases
依托 Certara 整合解决方案革新您的罕见病药物开发。从临床前研究洞见到市场准入策略，我们以卓越的专业知识全程护航药物开发全流程。
